expression of CD62L on resting monocytes was lower during the 3rd (p = 0.001) and the 5th (p = 0.001) year in patients. Levels of tumor necrosis factor-α and RANTES were significantly increased (p = 0.001, p = 0.006) and interleukin-12 levels were also higher in CKD patients during the 5th year (p = 0.007). Conclusion: Monocytes in CKD stages 2-3 show emerging functional abrasions, with altered adhesion molecule expression and impaired fMLP response. These findings suggest that a transformation of monocyte function occurs at an early phase of renal impairment and may together with increased plasma levels of pro-inflammatory cytokines contribute to the higher vulnerability of CKD patients to comorbidities, such as infections and cardiovascular disease.
phases of disease. In the end-stage renal disease, the risk of morbidity and mortality magnifies, essentially due to cardiovascular diseases and infections [5] [6] [7] . Alterations occur in both innate and adaptive immune responses in CKD due to uremia, dialysis procedures and oxidative stress [8] [9] [10] [11] . CKD patients are subjected to a state of chronic inflammation [12] , a condition reflected in consequential imbalance of pro-and anti-inflammatory cytokines [13] [14] [15] [16] . While mediating cell adhesion, integrins and selectins participate in cell development, proliferation, migration and apoptosis. Deficit or aberrant expression of specific adhesion molecules might contribute to inflammatory disease as well as to tumor development [17] [18] [19] .
Altered leukocyte function, recruitment and activation, as well as modified expression of adhesion molecules have been thoroughly described in advanced CKD [20] [21] [22] [23] [24] . Monocytes and macrophages have an important role in modulating inflammation and regulating the adaptive immune responses [25, 26] . We have previously shown how monocytes from patients with renal failure (CKD stages 4-5) display a lower expression of CD11b both on peripheral monocytes and in vivo transmigrated inflammatory monocytes [27] . This impairment seemed to be partially reversed following dialysis treatment, accompanied by a preserved response to stimulation with formyl-methyinoyl-leucyl-phenylalanine (fMLP) [28] . Patients with CKD in stages 4-5 express a higher proportion of the pro-inflammatory CD16+ monocyte subtype [29] . An increased number of CD16+ monocytes together with higher levels of tumor necrosis factor-α (TNF-α) and interleukin (IL)-12 reflects a systemic micro inflammatory milieu in advanced CKD [8] .
Given our previous observations of monocyte impairment at advanced stages of CKD, we aimed at performing a study of monocyte functionality at an earlier stage of renal disease (CKD stages 2-3). We analyzed the translocation and shedding of adhesion molecules, as well as oxidative metabolism in monocytes. Moreover, we explored the profile of cytokines and chemokines, as mediators of the underlying inflammatory milieu over the 5-year longitudinal study.
Materials and Methods

Study Population
Participants were enrolled from the prospective observational single-center cohort study, PROGRESS 2002, previously described in detail [30] . Briefly, 54 patients aged 18 to 62 with a glomerular filtration rate (GFR) of 50-70 ml/min/1.73 m 2 (CKD stages 2-3) were recruited from the Department of Nephrology at Karolinska University Hospital, Stockholm, Sweden. Patients with cancer, blood-borne disease, active infection or chronic inflammatory disease and those receiving immunosuppressive therapy were excluded from the study. CKD etiology ranged from primary glomerulonephritis (32%), congenital diseases (26%), secondary systemic disease (17%) and unknown cause of CKD (25%). Secondary systemic diseases included nephrosclerosis, diabetic nephropathy and 2 cases of SLE, but no vasculitis. The lupus patients did not show any signs of disease activity (high-sensitivity C-reactive protein (hsCRP)) at the respective measuring points. Healthy controls (n = 54) with GFR >80 ml/min/1.73 m 2 were recruited, all of them sexand age-matched (±2 years) with the CKD patients. Demographic characteristics are displayed in table 1 . The last patients were enrolled in 2009 and the cohort has been monitored during a followup time of 5 years. Blood samples and available general health information of patients were collected at baseline during the 3rd and 5th years. Written informed consent was obtained from all participants. The study was approved by the local Ethics Committee at the Karolinska University Hospital, Stockholm, Sweden (02-052, 2007/763-31/3).
GFR Measurement and Estimation
All participants had GFR measured by iohexol at inclusion. During the 3rd and the 5th year, GFR measured by iohexol was repeated in CKD patients, while an estimated GFR (eGFR) was calculated by creatinine-based CKDEPI formula in the controls. 270 CKDEPI eGFR validity was established by comparing each participant's iohexol outcome with the result from CKDEPI calculation at baseline, as well as by relating the results from both methods in the CKD group at follow-up.
Collection of Biomarkers in Blood and Urine
Phlebotomy was performed at the out clinic by trained personnel. Concentration of hsCRP, phosphate, parathyroid hormone and hemoglobin were analyzed according to routine protocol. Albuminuria was detected by the measurement of daily urinary excretion rate in mg/24 h (urine albumin excretion (UAE)).
Collection of Blood Samples for Monocyte Analysis
Whole blood was collected in citrate-containing tubes (Vacutainer, Becton Dickinson, UK) and kept on ice to avoid further complement activation and modulation of adhesion molecule expression on monocytes. To establish the number of leukocytes, 100 ml hemolyzed blood was stabilized and fixed according to the Multi-Q-prep, ImmunoPrep technique (Beckman Coulter Inc., USA) and cells calculated by flow cytometry (Beckman Coulter Inc., USA).
Preparation and Activation of Peripheral Monocytes
Blood samples (100 μl) were allocated in polystyrene tubes and erythrocytes were lysed by adding 2 ml cold isotonic solution (154 m M NH 4 Cl, 10 m M KHCO 3 , and 0.1 m M EDTA, pH 7.2). After 5 min, the tubes were centrifuged for 5 min at 300 g at 4 ° C, the supernatant was discarded and the cells were washed with cold phosphate-buffered saline (PBS). To study the capacity of leukocyte responsiveness (in form of CD11b upregulation), cells were incubated with fMLP (Sigma-Aldrich, Germany). The tubes were separated into 2 groups: the unstimulated (resting) cells, kept on ice, and cells stimulated with fMLP at final concentration of 5 × 10 -7 M at 37 ° C for 30 min. Then, the tubes were washed with PBS, and cells were resuspended in 100 μl of cold PBS. For analysis of CD62L expression, cells were kept on ice after the lysis procedure.
Flow Cytometric Analysis of CD11b and CD62L Expression on Monocytes
Anti-CD11b-PE (Dako, Glostrup, Denmark, 5 μl) was added to unstimulated and fMLP-stimulated cells, while anti-CD62L-FITC (Becton Dickinson, UK, 10 μl) was added to unstimulated assigned tubes, as well as corresponding isotype controls. After incubation for 30 min at 4 ° C, rinsing with 2 ml PBS followed. Centrifugation at 300 g for 5 min and the pellets were finally resuspended in 350 μl of cold PBS before subsequent analysis of the adhesion molecule expression using flow cytometry. Data acquisition was conducted by flow cytometer (Navios, Beckman Coulter Inc., Hialeah, Fla., USA) and the data were analyzed by the Kaluza software (Beckman Coulter Inc., USA). Monocytes were gated according to their size and granularity on forward and side scatter, using a standardized gating strategy with the monocytes gated in a cluster. The laboratory routine described above was considered a state-of-the-art method at the initiation of the study in 2002, and we decided on continuing with the same gating technique during the whole study. All methods and analyses in this study have been performed according to international standards in a Swedac accredited laboratory. Every sample was accompanied by a control sample from a healthy subject and analyses were performed within 4 h. The mean fluorescence intensity (MFI) of CD11b+ cells and CD62L+ cells was measured in accordance with the intensity of the gated population set by the respective isotype controls.
Analysis of Oxidative Metabolism (Respiratory Burst)
100 μl of blood was lysed, centrifuged and washed as described earlier. Cells were incubated with 200 μl of highly fluorescent 2 ′ 7 ′ -dichlorofluorescein diacetate (DCFH-DA; Sigma Chemical Co., UK) at a final concentration of 5 μ M , freshly diluted in 500 ml of PBS of pH 7.4, supplemented with 0.9 mg/ml glucose (PBS-glucose) for 15 min, at 37 ° C while being shaken gently in between. Following the load with DCFH-DA, cells were then stimulated with 5 × 10 -7 M fMLP, diluted in PBS-glucose, for 30 min, at 37 ° C. To provide negative controls, non-stimulated cells were treated with 200 μl PBS-glucose at 4 ° C. Addition of 1 ml cold PBS-azide supplemented with 0.1 m M EDTA and putting the samples on ice terminated the reaction. Flow cytometry was used to determine intracellular H 2 O 2 production reflected by MFI levels.
Determination of Soluble Inflammatory Mediators in Serum
The concentration of soluble inflammatory mediators, such as cytokines and chemokines were simultaneously analyzed in plasma samples by bead-based multiplex assays using the Milliplex 26-plex technology with Luminex technology (Millipore Corp., St. Charles, Missouri, USA), based on the provided manufacturers' protocol. We selected chemokines representing different aspects of the innate immune response. As representatives of the pro-inflammatory cytokine group, we choose TNF-α, and to display chemokine activity, we selected RANTES and finally IL-12 as a reflection of cell differentiation.
Statistical Analysis
Cell frequencies (%) were calculated for categorical variables and mean values (SD) for continuous variables. p values were calculated from chi-square tests (missing observations omitted) and Student's t test for the categorical variables and continuous variables, respectively.
The normality assumption of cytokine/chemokine (Luminex) data, and adhesion molecule and respiratory burst cell data was assessed graphically by histogram plots with associated kurtosis and skewness tests and by Shapiro-Wilk test. Furthermore, potential outlier values were examined graphically by box plotting the data. For normally distributed data, an absolute value bigger than 3, 5 * SDs above or below its calculated mean was defined as an outlier. For non-normal distributed data, an outlier was defined as an absolute value bigger than 10 * interquartile range from its calculated median. At baseline, year 3, and year 5, statistically significant differences between the groups were assessed by Student's t test and Mann-Whitney U test. Multiple comparisons testing were accounted for by Bonferroni correction (overall significance level α = 0.05). Delta values were calculated for cytokine/chemokine and cell data according to the formula: Y i delta = X i t = 5 -X i t = 0 , where X is the measured value at time t for individual i. Analysis of differences in progression of cytokine/chemokine and cell data between groups was performed by Student's t test and Mann-Whitney U test. Additionally, generalized linear regression models were calculated to compare and quantify differences between the study groups (data not shown). All analyses were performed by the t test, rank-sum, and regress commands in STATA 14.1 (StataCorp, College Station, Tex., USA). 
Results
Glomerular Filtration Rate
At baseline, the iohexol clearance (ml/min/1.73 m 2 ) mean value was 60.2 ± 5.2 in the patient group and 99.2 ± 11.9 in the controls group (p < 0.001), while with CKDEPI (ml/min/1.73 m 2 ), the mean eGFR in the groups was 59.2 ± 14.7 and 96.4 ± 13.3, respectively. During the 3rd year, the CKD patients had an iohexol clearance of 57.5 ± 18.1 with a corresponding CKDEPI eGFR of 54.5 ± 16.5, while the controls had a CKDEPI eGFR of 95.2 ± 9.6. During the 5th year, patients had an iohexol clearance mean of 49.6 ± 16.8 and CKDEPI eGFR of 49.6 ± 16.8, compared to the control groups' final CKDEPI eGFR mean of 90.7 ± 11.1.
Biochemical Markers and Clinical Data
At baseline, 23 patients were being treated with angiotensin converting enzyme inhibitors (ACEi) and 22 angiotensin receptor blockers (ARBs). During the 3rd year, ACEi was prescribed to 31 patients (57%) and 32 had ARB (59%). During the 5th year, the number of ACEi treated remained unchanged, whereas ARBs had increased to 35 (65%) patients. Thirteen patients were prescribed statins at baseline, 23 patients (43%) at year 3 and 20 patients at year 5 (37%). The mean arterial pressure in patients was significantly higher (p = 0.043) at baseline compared to the controls ( table 1 ) . There were no significant differences in body mass index at baseline or change in body mass over time in either group.
Patients had significantly lower hemoglobin levels, whereas UAE and hsCRP were significantly higher as compared to controls ( table 2 ) .
Adhesion Molecules on Monocytes and Oxidative Metabolism (Respiratory Burst)
The number of peripheral monocytes was equal among the patients and controls. At baseline, there were no significant differences in the expression of CD11b or CD62L on resting monocytes. A higher expression of CD11b on fMLP-stimulated monocytes was observed in the patient group. However, at follow-up, CKD patients had developed a significantly lower response to fMLP stimulation in expression of CD11b ( table 3 ) . There was a significantly lower delta value (i.e. significantly lower increase over time) of CD11b expression at the resting state as compared with healthy controls. CD62L had a significantly lower expression on monocytes in CKD patients, both during the 3rd year and the 5th year of the study. CD62L displayed a significantly lower delta value in CKD patients compared to healthy controls ( table 3 ) . There was no significant difference in H 2 O 2 production at baseline or at follow-up, but stimulation with fMLP resulted in a significantly lower oxidative burst response in monocytes over time in CKD patients ( table 3 ) .
Pro-Inflammatory Molecules: Cytokines and Chemokines
At all measurements, TNF-α was significantly higher in the CKD group. RANTES and IL-12 were both significantly higher at baseline and during the 5th year of study as well as increased significantly more over time in CKD patients ( table 4 ).
Discussion
In this 5-year observational study on patients with early CKD, we analyzed CD11b and CD62L as markers of extravasation and initiated adhesion of monocytes. There was a significantly higher expression of adhesion molecule CD11b on fMLP-stimulated cells in patients at baseline, while no significant difference compared to healthy subjects was observed in CD11b on resting monocytes. However, follow-up data showed significantly lower CD11b expression on resting and stimulated monocytes in CKD patients. Under non-inflammatory circumstances, peripheral monocytes express a low amount of surface CD11b/CD18. Inflammatory stimuli, however, rapidly recruit them to the cell surface, making CD11b a reliable marker of initiated extravasation of monocytes [17, 19, 31, 32] . We have previously shown that peripheral resting monocytes from patients with advanced renal failure (CKD stages 4-5) express a lower level of CD11b, when compared to healthy controls [27] . At baseline in this study, we found the expression of CD11b on resting monocytes in patients to be comparable with controls, but over 5 years a lower CD11b expression occurred in the CKD group. These findings suggest that monocytes are in a restored state at earlier phases of CKD, reflected in a normal expression of CD11b. However, a lower CD11b expression evolves over time, and this finding supports our previous findings [27] . Interestingly, following stimulation with fMLP, we observed a higher expression of CD11b on the surface of patients' monocytes at baseline. This may suggest an inclination of these cells to translocate the intracellular stored CD11b to the surface, possibly due to a higher responsiveness of primed cells in the inflammatory milieu. In contrast to the Analyzed by Mann-Whitney U test and by Student's t test for hemoglobin levels, reported as median (interquartile range) and mean (±SD), respectively. 273 baseline value, a significant decline in the CD11b expression occurred following stimulation with fMLP, both during the 3rd and 5th years. This may reflect an inability to mobilize CD11b from the intracellular vesicles or a refractoriness of monocytes exhausted by the constant inflammatory burden of renal insufficiency [23, 27-29, 33, 34] . A preserved response of monocytes to fMLP stimulation was previously found in patients treated with high-flux hemodialysis [23] , perhaps indicating a reversibility of this cellular refractory effect by hemodialysis. A low response to fMLP may contribute to the elevated susceptibility to infections in CKD patients. Impaired kidney function alters several hormonal pathways, but it is not fully understood whether these changes play any significant role in inflammation or enhances kidney injury [35] . Research studies are known to enhance life style awareness and impact behavior in all participants, influencing health and eliciting a domino effect reaching the cellular level. Both hormonal and research commitment-related factors might contribute to the altered responsiveness of CD11b expression over time in our cohort.
Following activation and adhesion of monocytes, CD62L is rapidly enzymatically cleaved and shed from the cell surface [36] [37] [38] . In previous studies of advanced CKD, monocytes displayed a lower CD62L expression [27] . In this study, the CD62L level on monocytes was comparable to that of healthy controls at baseline but showed a significant lower expression during the 3rd and the 5th year in CKD patients. Perhaps this implies a better feature of monocytes at earlier phase of renal impairment, but a lower translocation, or higher shedding of CD62L over time, probably due to the impact of prolonged exposure to aggregated inflammatory mediators. TNF-α is a pro-inflammatory molecule believed to induce shedding of CD62L [36, 37, 39] . We observed a significant increase in TNF-α levels over 5 years, while we noted a significant lower expression of CD62L levels in CKD patients at follow-up, which is in line with this hypothesis.
Measurements of respiratory burst mirror the intracellular killing capacity of monocytes. We found a significantly impaired oxidative metabolic response to fMLP over time in monocytes from CKD patients. This adds to our previous cross-sectional study in which peripheral monocytes from hemodialysis patients had a preserved respiratory burst, and suggests that the inflammatory milieu imposes a refractory state on monocytes. However, transmigrated cells might perform differently.
Pretreatment of neutrophils with phosphaturic hormone FGF-23, known to increase substantially in CKD, has shown disabled production of reactive oxygen species as well as interference with integrin recruitment and chemokine signaling [40] .
In this study, significantly higher levels of TNF-α, IL-12 and RANTES were found in plasma from patients, compared to those in healthy controls. Notably, levels of chemokines in general tended to fluctuate over time, which most likely reflects a variability of the inflammatory process. Elevated cytokine levels in advanced CKD are partly due to a reduced renal clearance but may also be a result of an increased production from dendritic cells that are stimulated by retained toxins [15] . However, at the early stage of renal disease, an accumulation is less plausible and elevated levels would probably result from an actual pathogenic mechanism rather than from a decline in filtration rate.
Augmented production of pro-inflammatory cytokines such as TNF-α, IL-1, IL-8, IL-15 and IL-12 has been shown in both pre-dialysis and in hemodialysis groups, indicating a role of uremic milieu in this process, independent of the dialysis treatment [16] . Aberrant IL-12 expression has been reported in infectious, autoimmune, inflammatory conditions and atherosclerosis, modulating the adaptive immune response [41] . RANTES modulates the migration of monocytes by inducing the expression of CD11b/CD18 [42] . Elevated levels of RANTES have been associated with sustained inflammation and multiple immune-mediated diseases [43, 44] . Moreover, TNF-α is known to induce production of RANTES under inflammatory conditions [45] . Elevated levels of RANTES, TNF-α and IL-12 after 5 years of observation are an indication of a gradually higher inflammatory state in the CKD group. There are other possible cellular sources of chemokines than monocytes to consider in hyper-inflammatory conditions [46, 47] . Studies of innate immunity in the elderly have revealed an accumulation of cytokines causing detrimental inflammation ensuing cardiovascular disease, sarcopenia and metabolic derangement [48] [49] [50] -characteristics highly comparable to the clinical state of CKD. Nevertheless, aging instigates a general downregulation of the innate immune system [51] , somewhat compensated by enhanced cytokine production, while the elevated cytokine levels and eventually refractory leukocytes seen in CKD origin from the constant exposure to endogenous accumulated toxins. However, eventually both groups develop a pro-inflammatory environment and persistent low-grade innate immune activation.
The counterbalance act of the innate immunity is crucial to avoid tissue damage. The altered monocyte function and excessive pro-inflammatory cytokine expression in our CKD stages 2-3 cohort might imply dual consequences of the distorted innate immune system. Alterations in chemokine levels as well as in adhesion molecule expression might potentially act either harmful or protective. We cannot rule out that a lower expression of adhesion molecules might function as an anti-inflammatory adaptive response. Perhaps there is a dysregulation rather than a dysfunction of the innate immunity network, inducing the inflammation in CKD. Nonetheless, increased susceptibility of infections could potentially partly originate from impaired monocyte recruitment. Moreover, inflammatory monocytes and elevated levels of pro-inflammatory cytokines might contribute to enhanced vascular plaque formation as well as changes in cardiac function and structure, leading to cardiovascular morbidity. All these possible links warrants further studies.
Conclusion
Our data indicate an elevation of pro-inflammatory cytokines as well as monocytes with functional abrasions at mild to moderate renal impairment. This might suggest these conditions as potential contributors to the progression of kidney disease as well as to infectious and cardiovascular comorbidities in CKD.
